SIGLEC1 and neoplasm: Second, increased numbers of CD169+F4/80+CD11b+CD45+ macrophages were observed in the treated tumor region and spleen, which might suggest a role for these CD169+ macrophages in CD8+ T lymphocyte activation for elimination of the tumor (26).